Operating

Other Working Capital

Bristol-Myers Squibb Other Working Capital increased by 253.2% to $1.64B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 54.5%, from $1.06B to $1.64B.

Analysis

StatementCash Flow Statement
SectionOperating
CategoryEfficiency
SignalContext dependent
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026Apr 30, 2026

How to read this metric

Large fluctuations may indicate timing differences in tax payments, accruals, or other non-core operational shifts.

Detailed definition

Captures the net impact of changes in operating assets and liabilities not categorized as accounts receivable, inventory...

Peer comparison

Varies significantly by industry; peers with similar business models should show comparable trends in accrual management.

Metric ID: change_in_other_working_capital

Historical Data

10 periods
 Q1 '22Q2 '22Q3 '22Q1 '23Q3 '23Q1 '24Q4 '24Q1 '25Q4 '25Q1 '26
Value$1.07B$191.00M$46.00M$1.06B$59.00M$608.00M-$725.00M$1.06B-$1.07B$1.64B
QoQ Change-82.2%-75.9%>999%-94.5%+930.5%-219.2%+246.1%-200.8%+253.2%
YoY Change-0.8%+28.3%-42.9%+74.2%-47.3%+54.5%
Range-$1.07B$1.64B
CAGR+20.6%
Avg YoY Growth+11.0%
Median YoY Growth+13.7%

Frequently Asked Questions

What is Bristol-Myers Squibb's other working capital?
Bristol-Myers Squibb (BMY) reported other working capital of $1.64B in Q1 2026.
How has Bristol-Myers Squibb's other working capital changed year-over-year?
Bristol-Myers Squibb's other working capital increased by 54.5% year-over-year, from $1.06B to $1.64B.
What does other working capital mean?
Net cash impact from changes in miscellaneous operating assets and liabilities.